Authors

• Jerome De Seze (ORCID: https://orcid.org/0000-0002-7197-7578)
• Valentine Jehl
• Xixi Hu
• Sven Guenther Meuth (ORCID: https://orcid.org/0000-0003-2571-3501)
• Jin Nakahara (ORCID: https://orcid.org/0000-0002-5858-0998)
• Heinz Wiendl (ORCID: https://orcid.org/0000-0003-4310-3432)
• Ibolya Boer
• Derrick Robertson (ORCID: https://orcid.org/0000-0001-8993-0981)
• Jeffrey Allen Cohen (ORCID: https://orcid.org/0000-0001-9245-9772)
• Rebecca Piccolo (ORCID: https://orcid.org/0009-0006-8908-8660)
• Ludwig Kappos
• Paul S. Giacomini (ORCID: https://orcid.org/0000-0002-1346-3042)
• Roseanne Sullivan (ORCID: https://orcid.org/0000-0001-6025-465X)
• Jing Xi (ORCID: https://orcid.org/0000-0002-7546-3099)
• Celia Oreja‐Guevara
• Stephen L. Hauser (ORCID: https://orcid.org/0000-0002-4932-4001)
• Alit Bhatt
• Sibyl Wray

Institutions

• Universidad Complutense de Madrid (ES)
• Novartis (Switzerland) (CH)
• Montreal Neurological Institute and Hospital (CA)
• Cleveland Clinic (US)
• University of California, San Francisco (US)
• Keio University (JP)
• University of South Florida (US)
• University Medical Center Freiburg (DE)
• University Hospital of Basel (CH)
• Hospital Clínico San Carlos (ES)
• Novartis (India) (IN)
• Novartis (China) (CN)
• Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (ES)
• University Hospital Münster (DE)
• Novartis (United States) (US)
• Department of Biomedicine Basel (CH)
• Heinrich Heine University Düsseldorf (DE)
• Université de Strasbourg (FR)

Publication Details

Journal

Neurology and Therapy

Published

2025-07-13

DOI

https://doi.org/10.1007/s40120-025-00784-0

Citations

8

Primary Topic

Multiple Sclerosis Research Studies

Type

article

Field-Weighted Citation Impact

11.77

Funders

• Bristol-Myers Squibb
• Pfizer
• Novartis
• Sanofi
• Biogen
• Patient-Centered Outcomes Research Institute
• Teva Pharmaceutical Industries
• Alexion Pharmaceuticals
• Celgene
• F. Hoffmann-La Roche
• CSL Behring
• TG Therapeutics
• GW Pharmaceuticals
• BioCryst
• Amicus Therapeutics
• Atara Biotherapeutics
• Argenx
• Multiple Sclerosis Society
• Ministry of Education, Culture, Sports, Science and Technology
• Fondazione Cariplo
• Ministry of Health, Labour and Welfare
• Shionogi
• Schweizerische Multiple Sklerose Gesellschaft
• Idorsia Pharmaceuticals
• Genentech
• Samsung
• EMD Serono
• Sanofi Genzyme
• Greenwich Biosciences